GKOS: Glaukos Corporation Stocks News on July 9, 2025

Glaukos gains EU certification for iStent infinite and other MIGS devices

GKOS

Medical Device Network

12 days ago

Glaukos gains EU certification for iStent infinite and other MIGS devices

GKOS

MT Newswires

14 days ago

Glaukos Receives EU Regulatory Certification for Devices and Technologies to Treat Glaucoma

Glaukos Announces EU MDR Certification for iStent infinite® and Other Leading MIGS Therapies

GKOS

Business Wire

14 days ago

Glaukos Announces EU MDR Certification for iStent infinite® and Other Leading MIGS Therapies

NYSE Content Advisory: Pre-Market update + S&P 500 trades within 1% of record

GKOS

PR Newswire

14 days ago

NYSE Content Advisory: Pre-Market update + S&P 500 trades within 1% of record

Glaukos to Celebrate 10th Anniversary of IPO Listing with NYSE Closing Bell

GKOS

Business Wire

14 days ago

Glaukos to Celebrate 10th Anniversary of IPO Listing with NYSE Closing Bell

GKOS

Argus Research

15 days ago

GKOS: What does Argus have to say about GKOS?

GKOS

Zacks

23 days ago

What Makes Glaukos (GKOS) a New Buy Stock

GKOS

Zacks

a month ago

Can Glaukos (GKOS) Climb 34.4% to Reach the Level Wall Street Analysts Expect?

GKOS

Simply Wall St.

a month ago

Those who invested in Glaukos (NYSE:GKOS) three years ago are up 120%

Here's Why You Should Retain Glaukos Stock in Your Portfolio

GKOS

Zacks

2 months ago

Here's Why You Should Retain Glaukos Stock in Your Portfolio

GKOS

Argus Research

2 months ago

GKOS: Raising target price to $102.00

GKOS

Argus Research

2 months ago

GKOS: Raising target price to $97.00

Glaukos Announces Participation in Upcoming Investor Conferences

GKOS

Business Wire

2 months ago

Glaukos Announces Participation in Upcoming Investor Conferences

GKOS

Insider Monkey

2 months ago

Glaukos Corporation (GKOS) Fell as its iDose Results Fell Short of Expectations

GKOS

Argus Research

2 months ago

GKOS: Lowering target price to $92.00

Glaukos First Quarter 2025 Earnings: Beats Expectations

GKOS

Simply Wall St.

2 months ago

Glaukos First Quarter 2025 Earnings: Beats Expectations

GKOS

Zacks

2 months ago

Glaukos (GKOS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

GKOS

Zacks

2 months ago

GKOS Stock Falls Despite Q1 Earnings & Revenue Beat, Margins Decline

GKOS

Thomson Reuters StreetEvents

2 months ago

Q1 2025 Glaukos Corp Earnings Call

GKOS

MT Newswires

2 months ago

Truist Adjusts Price Target on Glaukos Corp to $135 From $140, Maintains Buy Rating

GKOS

GuruFocus.com

2 months ago

Glaukos Corp (GKOS) Q1 2025 Earnings Call Highlights: Record Sales and Strategic Growth Amid ...

GKOS

Zacks

2 months ago

Glaukos (GKOS) Reports Q1 Loss, Tops Revenue Estimates

GKOS

Associated Press Finance

2 months ago

Glaukos: Q1 Earnings Snapshot

Glaukos Announces First Quarter 2025 Financial Results

GKOS

Business Wire

2 months ago

Glaukos Announces First Quarter 2025 Financial Results

Earnings Preview: Mettler-Toledo (MTD) Q1 Earnings Expected to Decline

GKOS

Zacks

3 months ago

Earnings Preview: Mettler-Toledo (MTD) Q1 Earnings Expected to Decline

GKOS

Zacks

3 months ago

Glaukos (GKOS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

$Glaukos to Present Multiple Scientific Abstracts at the 2025 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting$

GKOS

Business Wire

3 months ago

Glaukos to Present Multiple Scientific Abstracts at the 2025 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

GKOS

Argus Research

3 months ago

GKOS: Lowering target price to $94.00

Glaukos Announces the Release of its 2024 Sustainability Report

GKOS

Business Wire

3 months ago

Glaukos Announces the Release of its 2024 Sustainability Report

GKOS

Argus Research

3 months ago

GKOS: Raising target price to $99.00

GKOS

MT Newswires

3 months ago

Truist Cuts Price Target on Glaukos to $140 From $185, Keeps Buy Rating

Strength Seen in Veracyte (VCYT): Can Its 13.0% Jump Turn into More Strength?

GKOS

Zacks

3 months ago

Strength Seen in Veracyte (VCYT): Can Its 13.0% Jump Turn into More Strength?

Glaukos to Release First Quarter 2025 Financial Results after Market Close on April 30

GKOS

Business Wire

3 months ago

Glaukos to Release First Quarter 2025 Financial Results after Market Close on April 30

GKOS

Argus Research

3 months ago

GKOS: Lowering target price to $86.00

GKOS

Insider Monkey

3 months ago

What Makes Glaukos Corporation (GKOS) a Compelling Stock?

GKOS

Argus Research

3 months ago

GKOS: Rating increased to a HOLD

GKOS

Zacks

3 months ago

The Zacks Analyst Blog Highlights Alcon, Glaukos and Regeneron Pharmaceuticals

3 Stocks to Watch in the Evolving Cell-Based Ophthalmic Therapy Space

GKOS

Zacks

3 months ago

3 Stocks to Watch in the Evolving Cell-Based Ophthalmic Therapy Space

GKOS

Argus Research

3 months ago

GKOS: Raising target price to $86.00

GKOS

Simply Wall St.

4 months ago

Breakeven On The Horizon For Glaukos Corporation (NYSE:GKOS)

GKOS

Zacks

4 months ago

Here's Why You Should Retain Glaukos Stock in Your Portfolio

RadiusXR and Glaukos Corporation Announce a New Collaboration With Topcon Healthcare, Inc. and the Launch of Inspire®: A Next-Generation Visual Field Solution

GKOS

Business Wire

4 months ago

RadiusXR and Glaukos Corporation Announce a New Collaboration With Topcon Healthcare, Inc. and the Launch of Inspire®: A Next-Generation Visual Field Solution

GKOS

Insider Monkey

4 months ago

Is Glaukos Corporation (GKOS) the Best Medical Technology Stock to Buy According to Analysts?

GKOS

Argus Research

4 months ago

GKOS: Lowering target price to $90.00

GKOS

MT Newswires

4 months ago

Glaukos Insider Sold Shares Worth $2,497,335, According to a Recent SEC Filing

GKOS

Zacks

4 months ago

GKOS Crashes Almost 25% After Q4 Earnings: How to Play the Stock?

GKOS

Argus Research

4 months ago

GKOS: Lowering target price to $96.00

GKOS

MT Newswires

5 months ago

Glaukos's Corneal Disease Drug Accepted for FDA Review

Glaukos Announces FDA Acceptance of NDA Submission for Epioxa™

GKOS

Business Wire

5 months ago

Glaukos Announces FDA Acceptance of NDA Submission for Epioxa™

GKOS

Simply Wall St.

5 months ago

We're Not Worried About Glaukos' (NYSE:GKOS) Cash Burn

Wingstop Stock’s Dip Is an Opportunity, Analyst Says. Plus, Devon Energy, Cadence Design, and More.

GKOS

Barrons.com

5 months ago

Wingstop Stock’s Dip Is an Opportunity, Analyst Says. Plus, Devon Energy, Cadence Design, and More.

GKOS

Zacks

5 months ago

GKOS Stock Falls Despite Q4 Earnings & Revenue Beat, Margins Decline

GKOS

GuruFocus.com

5 months ago

Glaukos Corp (GKOS) Q4 2024 Earnings Call Highlights: Record Sales and Strategic Growth Amid ...

GKOS

Zacks

5 months ago

Glaukos (GKOS) Reports Q4 Loss, Tops Revenue Estimates

GKOS

Associated Press Finance

5 months ago

Glaukos: Q4 Earnings Snapshot

GKOS

MT Newswires

5 months ago

Glaukos Q4 Non-GAAP Loss Narrows, Sales Rise

Glaukos Announces Fourth Quarter and Full Year 2024 Financial Results

GKOS

Business Wire

5 months ago

Glaukos Announces Fourth Quarter and Full Year 2024 Financial Results

Apple unveils iPhone 16e, Arista reports Q4 beat: Morning Buzz

GKOS

TipRanks

5 months ago

Apple unveils iPhone 16e, Arista reports Q4 beat: Morning Buzz

GKOS

GuruFocus.com

5 months ago

What To Expect From Glaukos Corp (GKOS) Q4 2024 Earnings

GKOS

MT Newswires

5 months ago

Mizuho Upgrades Glaukos Corp to Outperform From Neutral, Adjusts Price Target to $200 From $140

What to Expect From These 3 MedTech Stocks This Earnings Season?

GKOS

Zacks

5 months ago

What to Expect From These 3 MedTech Stocks This Earnings Season?

GKOS

Argus Research

5 months ago

GKOS: Raising target price to $138.00

GKOS

Zacks

5 months ago

What Analyst Projections for Key Metrics Reveal About Glaukos (GKOS) Q4 Earnings

Here's Why You Should Retain Glaukos Stock in Your Portfolio Now

GKOS

Zacks

5 months ago

Here's Why You Should Retain Glaukos Stock in Your Portfolio Now

GKOS

Argus Research

5 months ago

GKOS: Lowering target price to $139.00

Mesa Labs (MLAB) Q3 Earnings and Revenues Beat Estimates

GKOS

Zacks

5 months ago

Mesa Labs (MLAB) Q3 Earnings and Revenues Beat Estimates

GKOS

Simply Wall St.

5 months ago

Glaukos Corporation's (NYSE:GKOS) Intrinsic Value Is Potentially 90% Above Its Share Price

GKOS

Argus Research

5 months ago

GKOS: Raising target price to $140.00

Glaukos to Release Fourth Quarter and Full Year 2024 Financial Results after Market Close on February 20

GKOS

Business Wire

6 months ago

Glaukos to Release Fourth Quarter and Full Year 2024 Financial Results after Market Close on February 20

NeuroPace (NPCE) Soars 9.1%: Is Further Upside Left in the Stock?

GKOS

Zacks

6 months ago

NeuroPace (NPCE) Soars 9.1%: Is Further Upside Left in the Stock?

GKOS

Argus Research

6 months ago

GKOS: Raising target price to $139.00

GKOS

Zacks

6 months ago

GKOS Stock Gains Following Positive Study Data on iDose Platform

GKOS

Argus Research

6 months ago

GKOS: Lowering target price to $133.00

Glaukos Announces Positive Clinical Updates for its iDose® Sustained-Release Procedural Pharmaceutical Platform

GKOS

Business Wire

6 months ago

Glaukos Announces Positive Clinical Updates for its iDose® Sustained-Release Procedural Pharmaceutical Platform

Here's Why You Should Add Glaukos Stock to Your Portfolio Now

GKOS

Zacks

6 months ago

Here's Why You Should Add Glaukos Stock to Your Portfolio Now

Glaukos Reaches 52-Week High: What's Driving the Stock's Rally?

GKOS

Zacks

6 months ago

Glaukos Reaches 52-Week High: What's Driving the Stock's Rally?

Glaukos price target raised to $157 from $149 at BTIG

GKOS

TipRanks

6 months ago

Glaukos price target raised to $157 from $149 at BTIG

GKOS

MT Newswires

6 months ago

Stifel Adjusts Price Target on Glaukos to $175 From $153, Keeps Buy Rating

Glaukos Stock Down Despite NDA Submission of Epioxa to the FDA

GKOS

Zacks

6 months ago

Glaukos Stock Down Despite NDA Submission of Epioxa to the FDA

GKOS

MT Newswires

7 months ago

Glaukos Insider Sold Shares Worth $498,716, According to a Recent SEC Filing

GKOS

MT Newswires

7 months ago

Glaukos Insider Sold Shares Worth $1,502,800, According to a Recent SEC Filing

GKOS

Argus Research

7 months ago

GKOS: Raising target price to $130.00

Glaukos Submits New Drug Application to U.S. FDA for Epioxa™

GKOS

Business Wire

7 months ago

Glaukos Submits New Drug Application to U.S. FDA for Epioxa™

GKOS

Simply Wall St.

7 months ago

The three-year returns have been stellar for Glaukos (NYSE:GKOS) shareholders despite underlying losses increasing

Glaukos price target raised to $185 from $152 at Truist

GKOS

TipRanks

7 months ago

Glaukos price target raised to $185 from $152 at Truist

GKOS

MT Newswires

7 months ago

Truist Securities Adjusts Price Target on Glaukos to $185 From $152, Keeps Buy Rating

GKOS

Argus Research

7 months ago

GKOS: Raising target price to $128.00

Glaukos Announces Participation in the J.P. Morgan Healthcare Conference

GKOS

Business Wire

7 months ago

Glaukos Announces Participation in the J.P. Morgan Healthcare Conference

GKOS

Zacks

7 months ago

The Zacks Analyst Blog Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen

GKOS

Zacks

7 months ago

Here's Why You Should Add Glaukos Stock to Your Portfolio Now

5 Medical Device Stocks That Survived the 2024 Market Volatility

GKOS

Zacks

7 months ago

5 Medical Device Stocks That Survived the 2024 Market Volatility

GKOS

MT Newswires

7 months ago

Citigroup Upgrades Glaukos to Buy From Neutral, Raises Price Target to $162 From $132

GKOS

Argus Research

7 months ago

GKOS: What does Argus have to say about GKOS?

GKOS

TipRanks

7 months ago

Glaukos initiated with a Buy at UBS

GKOS

MT Newswires

7 months ago

UBS Initiates Glaukos at Buy With $182 Price Target

GKOS

Argus Research

7 months ago

GKOS: Lowering target price to $120.00

Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos

GKOS

Benzinga

7 months ago

Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos

GKOS

MT Newswires

7 months ago

Morgan Stanley Downgrades Glaukos Corp to Underweight

GKOS

Argus Research

7 months ago

GKOS: Lowering target price to $121.00

Glaukos Stock Soars 77.9% Year to Date: What's Behind the Rally?

GKOS

Zacks

8 months ago

Latest Glaukos Corporation (GKOS) News on July 9, 2025

Share on Social Networks: